Otros idiomas Bio-Rad Laboratories, Inc.

Acciones

BIO

US0905722072

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 29/04/2024			Varia. Cinco días.	Varia. 1 de enero.
277,1 ^USD	+0,42 %		-1,08 %	-14,18 %

29/04	BIO-RAD LABORATORIES, INC. : RBC Capital Markets mantiene una recomendación de compra.	ZM
26/04	Bio-Rad Laboratories, Inc. Anuncia Cambios de Vicepresidente Ejecutivo y Presidente, Grupo de Ciencias de la Vida	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Bio-Rad Announces Life Science Group Management Changes	29/04
Bio-Rad Announces Life Science Group Management Changes	26/04
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group	26/04
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024	18/04
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS	15/04
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay	11/04
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay	11/04
Bio-Rad Laboratories COO Andrew Last to Retire in September	10/04
Bio-Rad’s Chief Operating Officer Andrew Last to Retire	10/04
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire	10/04
North American Morning Briefing : Focus Turns to -2-	04/04
Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center	25/03
Bio-Rad Laboratories Appoints Roop Lakkaraju as CFO	20/03
Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as Chief Financial Officer, Effective April 15, 2024	20/03
Bio-Rad Laboratories, Inc. Appoints Roop K. Lakkaraju as New Executive Vice President Effective April 15, 2024	20/03
Bio-rad Laboratories Insider Sold Shares Worth $1,008,000, According to a Recent SEC Filing	29/02
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day	22/02
Bio Rad Labs rises after posting upbeat fourth-quarter profit	16/02
Bio-Rad: Q4 Earnings Snapshot	15/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bio-Rad Laboratories, Inc.

Acciones

BIO

US0905722072

Otros idiomas

Filtros